YungShin Global Holding Corporation (TPE: 3705)

Market Cap	13.93B
Revenue (ttm)	7.82B
Net Income (ttm)	1.03B
Shares Out	266.36M
EPS (ttm)	3.86
PE Ratio	13.53
Forward PE	n/a
Dividend	2.30 (4.39%)
Ex-Dividend Date	Jun 24, 2024

Volume	115,088
Average Volume	243,188
Open	52.40
Previous Close	52.40
Day's Range	52.30 - 52.50
52-Week Range	45.80 - 63.30
Beta	0.07
RSI	32.56
Earnings Date	Mar 28, 2025

About YungShin Global Holding

YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, the United States, Mainland China, and Japan. It also is involved in trade, investment, and other related businesses; import and export trading; and sale of medicine. YungShin Global Holding Corporation was incorporated in 2011 and is headquartered in Taipei City, Taiwan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3705

Financial Performance

In 2023, YungShin Global Holding's revenue was 7.03 billion, a decrease of -3.88% compared to the previous year's 7.31 billion. Earnings were 827.30 million, a decrease of -1.40%.